Sodium‐glucose cotransporter 2 inhibitors: A comprehensive review from cells to bedside

Author:

Bagheri Bahador12ORCID,Yaribeygi Habib3,Taherifard Erfan4ORCID,Talasaz Azita Hajhossein5,Bagheri Haleh6ORCID,Darban Mahboubeh7,Tabrizi Reza8910,Najafi Siamak11,Khodadost Mahmoud12,Akbari Maryam13ORCID

Affiliation:

1. Cancer Research Center Semnan University of Medical Sciences Semnan Iran

2. Center for Molecular Cardiology University of Zurich Schlieren Switzerland

3. Research Center of Physiology Semnan University of Medical Sciences Semnan Iran

4. Department of Internal Medicine Shiraz University of Medical Sciences Fars Iran

5. Department of Pharmacotherapy and Outcome Sciences Virginia Commonwealth University Richmond Virginia USA

6. Department of Medical and Clinical Pharmacology, Centre of PharmacoVigilance and Pharmacoepidemiology, Faculty of Medicine Toulouse University Hospital (CHU) Toulouse France

7. Department of Internal Medicine Semnan University of Medical Sciences Semnan Iran

8. Noncommunicable Diseases Research Center Fasa University of Medical Sciences Fasa Iran

9. USERN office Fasa University of Medical Sciences Fasa Iran

10. Clinical Research Development Unit Fasa University of Medical Sciences Fasa Iran

11. Department of Internal Medicine Fasa University of Medical Sciences Fasa Iran

12. Department of Public Health Larestan University of Medical Sciences Larestan Iran

13. Health Policy Research Center, Institute of Health Shiraz University of Medical Sciences Shiraz Iran

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3